Chen J - Search Results

1

A New Era for Cancer Target Therapies: Applying Systems Biology and Computer-Aided Drug Design to Cancer Therapies.

Wong YH, Chiu CC, Lin CL, Chen TS, Jheng BR, Lee YC, Chen J, Chen BS. Wong YH, et al. Among authors: chen j, chen bs, chen ts. Curr Pharm Biotechnol. 2016;17(14):1246-1267. doi: 10.2174/1389201017666161019160606. Curr Pharm Biotechnol. 2016. PMID: 27774890 Review.

2

Value of peritoneal cytology in potentially resectable pancreatic cancer (Br J Surg 2013; 100: 1791-1796).

Chiu CC, Chen JJ, Su SB, Wang JJ. Chiu CC, et al. Among authors: chen jj. Br J Surg. 2014 Jul;101(8):1031. doi: 10.1002/bjs.9556. Br J Surg. 2014. PMID: 24915792 No abstract available.

3

Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.

Lai YH, Chen MH, Lin SY, Lin SY, Wong YH, Yu SL, Chen HW, Yang CH, Chang GC, Chen JJ. Lai YH, et al. Among authors: chen jj, chen hw, chen mh. Oncotarget. 2015 Sep 22;6(28):26252-65. doi: 10.18632/oncotarget.4761. Oncotarget. 2015. PMID: 26312766 Free PMC article.

4

Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods.

Wong YH, Lin CL, Chen TS, Chen CA, Jiang PS, Lai YH, Chu L, Li CW, Chen JJ, Chen BS. Wong YH, et al. Among authors: chen jj, chen bs, chen ca, chen ts. BMC Med Genomics. 2015;8 Suppl 4(Suppl 4):S4. doi: 10.1186/1755-8794-8-S4-S4. Epub 2015 Dec 9. BMC Med Genomics. 2015. PMID: 26680552 Free PMC article.

5

Study of the inhibitory effects on TNF-α-induced NF-κB activation of IMD0354 analogs.

Li YR, Lin CC, Huang CY, Wong YH, Hsieh CH, Wu HW, Chen JJW, Wu YS. Li YR, et al. Among authors: chen jjw. Chem Biol Drug Des. 2017 Dec;90(6):1307-1311. doi: 10.1111/cbdd.13032. Epub 2017 Jul 11. Chem Biol Drug Des. 2017. PMID: 28557295

6

Multifunctional transcription factor YY1: a therapeutic target in human cancer?

Wang CC, Chen JJ, Yang PC. Wang CC, et al. Among authors: chen jj. Expert Opin Ther Targets. 2006 Apr;10(2):253-66. doi: 10.1517/14728222.10.2.253. Expert Opin Ther Targets. 2006. PMID: 16548774 Review.

7

Acidic stress facilitates tyrosine phosphorylation of HLJ1 to associate with actin cytoskeleton in lung cancer cells.

Chen CH, Lin H, Chuang SM, Lin SY, Chen JJ. Chen CH, et al. Among authors: chen jj. Exp Cell Res. 2010 Oct 15;316(17):2910-21. doi: 10.1016/j.yexcr.2010.06.027. Epub 2010 Jul 13. Exp Cell Res. 2010. PMID: 20615403

8

The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.

Lai YH, Yu SL, Chen HY, Wang CC, Chen HW, Chen JJ. Lai YH, et al. Among authors: chen jj, chen hy, chen hw. Carcinogenesis. 2013 May;34(5):1069-80. doi: 10.1093/carcin/bgt005. Epub 2013 Jan 9. Carcinogenesis. 2013. PMID: 23306212

9

4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin.

Lin MS, Hong TM, Chou TH, Yang SC, Chung WC, Weng CW, Tsai ML, Cheng TR, Chen JJW, Lee TC, Wong CH, Chein RJ, Yang PC. Lin MS, et al. Among authors: chen jjw. Eur J Med Chem. 2019 Nov 1;181:111584. doi: 10.1016/j.ejmech.2019.111584. Epub 2019 Aug 2. Eur J Med Chem. 2019. PMID: 31419740

10

Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth.

Weng CW, Wei CH, Tsai JY, Lai YH, Chang GC, Chen JJW. Weng CW, et al. Among authors: chen jjw. Int J Mol Sci. 2022 Mar 23;23(7):3487. doi: 10.3390/ijms23073487. Int J Mol Sci. 2022. PMID: 35408854 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128,228 results

Search Page